These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 475865)

  • 21. Molecular basis of the antineoplastic activity of 3'-amino-3'-deoxythymidine.
    Chen MS; Woods KL; Prusoff WH
    Mol Pharmacol; 1984 May; 25(3):441-5. PubMed ID: 6727865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate di-n-butyl ester effects on thymidine metabolism.
    Beardsley GP; Rosowsky A; McCaffrey RP; Abelson HT
    Biochem Pharmacol; 1979 Oct; 28(20):3069-74. PubMed ID: 518705
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
    Kahilainen L; Bergstrom D; Kangas L; Vilpo JA
    Biochem Pharmacol; 1986 Dec; 35(23):4211-5. PubMed ID: 3790149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells.
    Muggia FM; Slowiaczek P; Tattersall MH
    Anticancer Res; 1987; 7(2):161-6. PubMed ID: 3592628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between the effects of cytostatic agents on leukemia L 1210 in vivo and in the short term test in vitro (author's transl)].
    Volm M; Hummel H; Mattern J
    Blut; 1977 Jul; 35(1):65-74. PubMed ID: 890146
    [No Abstract]   [Full Text] [Related]  

  • 27. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of methotrexate toxicity by dipyridamole.
    Nelson JA; Drake S
    Cancer Res; 1984 Jun; 44(6):2493-6. PubMed ID: 6586287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1971 Oct; 31(10):1429-33. PubMed ID: 5095131
    [No Abstract]   [Full Text] [Related]  

  • 31. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
    Schwartz HS
    Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of combination treatment with adriamycin and methotrexate on the survival time of leukemic (L 1210) mice.
    Miyakawa A; Padarathsingh M; Vadlamudi S; Goldin A
    Chemotherapy; 1973; 19(1):38-46. PubMed ID: 4747574
    [No Abstract]   [Full Text] [Related]  

  • 33. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of methotrexate toxicity by thymidine: sequence-dependent biochemical effects.
    Jackson RC
    Mol Pharmacol; 1980 Sep; 18(2):281-6. PubMed ID: 7421796
    [No Abstract]   [Full Text] [Related]  

  • 35. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
    Venditti JM; Kline I; Tyrer DD; Goldin A
    Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines.
    Harrap KR; Taylor GA; Browman GP
    Chem Biol Interact; 1977 Jul; 18(1):119-28. PubMed ID: 302148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS; Fischer PH; Prusoff WH
    Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sites of action of amethopterin: intrinsic and acquired drug resistance.
    Harrap KR; Hill BT; Furness ME; Hart LI
    Ann N Y Acad Sci; 1971 Nov; 186():312-24. PubMed ID: 5289423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.